Non-Alcoholic Fatty Liver Disease
Conditions
Brief summary
The study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD
Detailed description
This study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD. Participants were randomly selected to participate in the study. Then divided into the groups (intervention and placebo). Intervention received supplementation for 12 weeks and placebo received same capsule was made for placebo groups.
Interventions
The intervention group received one capsule of multivitamin and minerals supplements every day, one hour after breakfast, for 12 weeks.
Placebo
Sponsors
Study design
Intervention model description
Intervention group received multivitamin and minerral
Eligibility
Inclusion criteria
* Participants with NAFLD diagnosed
Exclusion criteria
* subjects who in the last 6 months received vitamin or mineral supplementation, those with chronic conditions such as diabetes, hypertension, and heart disease, unwillingness to continue the study protocol, lactating women and pregnant women.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Multivitamin and minerals supplementation has role in reduce liver enzymes | 12 weeks | Multivitamin and minerals supplement was given for 12 weeks and has role in reduce Serum Bilirubin, alkaline phosphatase (ALP), alanine transaminase (ALT), and liver enzyme was measured by blood sampling tests. |
Countries
Iraq